On October 29, 2025, Sparrow BioAcoustics completed a $10 million financing round led by Killick Capital and Klister Credit, with participation from Pelorus VC, 98827 Newfoundland & Labrador Inc., and Brinex Capital. This funding will fuel Sparrow’s next stage of growth as hospitals across North America adopt its FDA-cleared Stethophone platform, the world’s first cardiac AI solution that uses bioacoustic technology to detect structural and rhythmic heart anomalies directly through a smartphone.
Cassels acted for Sparrow BioAcoustics.